FDA Drug Application (200793) for LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS by MATRIX LABS

Back to FDA Applications sponsored by MATRIX LABS

Application Number200793
Product Number001
FormTABLET, FOR SUSPENSION; ORAL
Dosage30MG; 50MG; 60MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS
Active IngredientLamivudine; Nevirapine; Zidovudine



Back to FDA Applications sponsored by MATRIX LABS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.